Conning’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-53,451
Closed -$5.53M – 628
2017
Q3
$5.53M Hold
53,451
– – 0.19% 96
2017
Q2
$2.4M Sell
53,451
-107,799
-67% -$4.25M 0.09% 163
2017
Q1
$5.9M Hold
161,250
– – 0.22% 87
2016
Q4
$4.9M Buy
+161,250
New +$5.07M 0.2% 97

Other funds holding ONC

Conning's ONC Position: Q4 2017 in Review

Conning sold out of BeOne Medicines (ONC) in Q4 2017, closing a stake of 53,451 shares — an estimated $5.53M sold.

Conning first reported a position in ONC in Q4 2016 and held it in 4 quarters. The position peaked at $5.9M in Q1 2017. 93 funds tracked by Wall St. Rank hold ONC as of Q4 2017.

  • Conning reported no remaining BeOne Medicines position as of Q4 2017 after selling out during the quarter.
  • Conning sold 53,451 BeOne Medicines shares in Q4 2017, an estimated $5.53M.
  • Conning first reported a position in BeOne Medicines in Q4 2016 and held it in 4 quarters.
  • Conning's BeOne Medicines position peaked at $5.9M in Q1 2017.
  • 93 funds tracked by Wall St. Rank held BeOne Medicines as of Q4 2017.

Based on Conning's 13F filing for Q4 2017, filed 30 Jan 2018.